MAVENCLAD vs MOZOBIL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. MAVENCLAD and MOZOBIL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MAVENCLAD	MOZOBIL
Rating	70/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CLADRIBINE	PLERIXAFOR
Manufacturer	Emd Serono	Genzyme
Dosage forms	Tablet	Injectable
Drug class	Purine Antimetabolite	Hematopoietic Stem Cell Mobilizer
Boxed warning	Boxed warning	None
Treats	Hairy Cell Leukemia, Non-Hodgkin Lymphoma, Multiple Sclerosis	Non-Hodgkin Lymphoma, Multiple Myeloma

mavenclad mozobil

Rating

70/100

72/100

Pharmacy pays

—

Type

Active ingredient

CLADRIBINE

PLERIXAFOR

Manufacturer

Emd Serono

Genzyme

Dosage forms

Tablet

Injectable

Drug class

Purine Antimetabolite

Hematopoietic Stem Cell Mobilizer

Boxed warning

None

Treats

Hairy Cell Leukemia, Non-Hodgkin Lymphoma, Multiple Sclerosis

Non-Hodgkin Lymphoma, Multiple Myeloma

Frequently asked questions

Which is better-rated, Mavenclad or Mozobil?

By our independent rating, Mozobil scores higher — 3.6 vs 3.5 out of 5 for Mavenclad. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Mavenclad and Mozobil?

Mavenclad contains Cladribine, while Mozobil contains Plerixafor — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.